Back

The PPARβ/δ-induced mesenchymal stromal cell secretome has cytoprotective effects via ANGPTL4 in a pre-clinical model of acute lung inflammation

Tunstead, C.; Dunlop, M.; Ryan, S.; Volkova, E.; Johnston, E.; Batah, S.; Dos Santos, C. C.; McNicholas, B.; Masterson, C.; Laffey, J. G.; English, K.

2025-07-31 immunology
10.1101/2025.07.28.667170 bioRxiv
Show abstract

RationaleHuman bone marrow-derived mesenchymal stromal cells (hBM-MSCs) are known to exert immunomodulatory and pro-reparative effects in vivo. This makes hBM-MSCs an enticing therapeutic candidate for inflammatory diseases, such as acute respiratory distress syndrome (ARDS). The ARDS microenvironment is complex and contains an abundance of free fatty-acids (FFAs); which are known to differentially impact MSC functionality. PPAR{beta}/{delta} is a ubiquitously expressed nuclear receptor that is activated in response to FFA-binding. It has shown to impact the therapeutic efficacy of mouse MSCs. ObjectiveThis study sought to investigate the impact of PPAR{beta}/{delta}-modulation on MSC functionality in vitro and in vivo. MethodshBM-MSCs were exposed to a synthetic PPAR{beta}/{delta} agonist/antagonist in the presence or absence of ARDS patient serum and the immunomodulatory and pro-reparative capacity of the MSC secretome was investigated using in vitro assays, and a pre-clinical model of LPS-induced acute lung inflammation (ALI). ResultsOur results highlighted that the secretome from PPAR{beta}/{delta}-agonised hBM-MSCs had enhanced pro-reparative capacity in CALU-3 lung epithelial cells by promoting the secretion of angiopoietin-like 4 (ANGPTL4). This PPAR{beta}/{delta}-induced ANGPTL4-high MSC secretome also showed enhanced cytoprotection, wound repair, and reduced pro-inflammatory cytokines in the bronchoalveolar lavage fluid (BALF) of mice in a pre-clinical model of ALI. Importantly LPS-ALI mice that received PPAR{beta}/{delta}-induced ANGPTL4-high MSC secretome had reduced clinical score and weight loss. This was confirmed using an anti-ANGPTL4 antibody. ConclusionThese findings conclude that the PPAR{beta}/{delta}-induced ANGPTL4-high MSC secretome has anti-inflammatory, reparative and cytoprotective effects in a pre-clinical model of ALI. Graphical Abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=145 SRC="FIGDIR/small/667170v1_ufig1.gif" ALT="Figure 1"> View larger version (44K): org.highwire.dtl.DTLVardef@f20161org.highwire.dtl.DTLVardef@38aebeorg.highwire.dtl.DTLVardef@1584e86org.highwire.dtl.DTLVardef@8b4227_HPS_FORMAT_FIGEXP M_FIG C_FIG

Published in The FASEB Journal (predicted rank #15) · training set

Matching journals

The top 14 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.